Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02561988
Recruitment Status : Recruiting
First Posted : September 29, 2015
Last Update Posted : November 11, 2019
Sponsor:
Information provided by (Responsible Party):
Blueprint Medicines Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 2021
Estimated Study Completion Date : December 2021